Efficacy of Mepolizumab in COPD Management

This chapter examines a clinical trial assessing the effectiveness of mepolizumab for patients with COPD and eosinophilic phenotype, finding a significant reduction in exacerbations. However, it highlights the absence of improvements in quality of life and lung function, suggesting more research is needed to better target patients.